TP63 and lung adenocarcinoma: To further characterize these tumors, we stained the tissues with two antibody combinations used by pathologists to differentiate lung adenocarcinomas (Napsin A + TTF1) [29] and squamous cell carcinomas (p63+CK5) [30].